Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
C 82.14 -1.91% -1.60
AXSM closed down 1.91 percent on Thursday, July 18, 2024, on approximately normal volume.
Earnings due: Aug 5
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Outside Day Range Expansion 0.00%
Stochastic Reached Overbought Strength -1.91%
Overbought Stochastic Strength -1.91%
Gapped Up Strength -3.31%
Overbought Stochastic Strength -3.31%
Inside Day Range Contraction -0.80%
Overbought Stochastic Strength -0.80%
Bearish Engulfing Bearish -0.83%
Slingshot Bullish Bullish Swing Setup -0.83%

   Recent Intraday Alerts

Alert Time
Outside Day about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 2 % about 21 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Fell Below 10 DMA about 22 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Clinical Development Alzheimer's Disease Chronic Pain Pain Management Central Nervous System Disorders Depression Nervous System Disorders Knee Osteoarthritis Chronic Condition Antidepressants Treatment Of Chronic Pain Back Pain Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.4
52 Week Low 55.0276
Average Volume 732,045
200-Day Moving Average 75.34
50-Day Moving Average 77.25
20-Day Moving Average 80.87
10-Day Moving Average 83.04
Average True Range 2.80
RSI (14) 55.56
ADX 16.63
+DI 24.82
-DI 15.71
Chandelier Exit (Long, 3 ATRs) 77.10
Chandelier Exit (Short, 3 ATRs) 80.42
Upper Bollinger Bands 86.16
Lower Bollinger Band 75.58
Percent B (%b) 0.62
BandWidth 13.08
MACD Line 2.07
MACD Signal Line 2.02
MACD Histogram 0.0508
Fundamentals Value
Market Cap 3.89 Billion
Num Shares 47.3 Million
EPS -4.57
Price-to-Earnings (P/E) Ratio -17.97
Price-to-Sales 20.74
Price-to-Book 17.03
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 88.11
Resistance 3 (R3) 88.57 87.03 87.12
Resistance 2 (R2) 87.03 85.51 86.81 86.78
Resistance 1 (R1) 84.59 84.57 83.82 84.13 86.45
Pivot Point 83.05 83.05 82.67 82.83 83.05
Support 1 (S1) 80.61 81.53 79.84 80.15 77.83
Support 2 (S2) 79.07 80.59 78.85 77.50
Support 3 (S3) 76.63 79.07 77.17
Support 4 (S4) 76.17